VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS) — VITALYST EFS

High-risk Percutaneous Coronary Intervention Clinical Trial

Official title:
VITALYST EFS: VITALYST Temporary Percutaneous Transvalvular Circulatory Support System Early Feasibility Study

Status Not yet recruiting

Clinical Trial Summary

The VITALYST Early Feasibility study (EFS) is designed to evaluate the feasibility and safety of the VITALYST System in subjects undergoing elective high-risk percutaneous coronary intervention (HR-PCI).

Clinical Trial Description

The VITALYST EFS is a prospective, open-label, single-arm, multicenter feasibility study of the VITALYST System. The VITALYST System will be used to provide temporary circulatory support in patients undergoing non-emergent high risk percutaneous interventions (HR-PCI). ;

Study Design

Related Conditions & MeSH terms

Coronary Disease
Heart Disease, Coronary
Heart Diseases
High-risk Percutaneous Coronary Intervention

Clinical Trial Details

NCT number	NCT06132568
Study type	Interventional
Source	Boston Scientific Corporation
Contact	Alison Osattin
Phone	800-876-9960
Email	alison.osattin@bsci.com
Status	Not yet recruiting
Phase	N/A
Start date	April 2024
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04477603` - Impella ECP Early Feasibility Study	N/A
Recruiting	`NCT05727059` - Magenta Elevate™ EFS in High-Risk PCI Patients	N/A
Recruiting	`NCT04321148` - Protect Kidney Trial	N/A
Enrolling by invitation	`NCT05334784` - Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol	N/A
Active, not recruiting	`NCT06099548` - Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients	N/A